SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-090925
Filing Date
2024-04-09
Accepted
2024-04-09 16:55:36
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d802332ds3.htm S-3 212828
2 EX-5.1 d802332dex51.htm EX-5.1 8785
3 EX-23.1 d802332dex231.htm EX-23.1 1652
4 EX-FILING FEES d802332dexfilingfees.htm EX-FILING FEES 10041
5 GRAPHIC g802332g0406054834362.jpg GRAPHIC 2533
6 GRAPHIC g802332g30q47.jpg GRAPHIC 76294
  Complete submission text file 0001193125-24-090925.txt   343252
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278581 | Film No.: 24833348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)